|
| Press Releases |
|
 |
|
| Wednesday, March 9, 2022 |
|
|
Eisai Certified as the 2022 Health and Productivity Management Outstanding Organization (White 500) |
| Eisai Co., Ltd. announced today that it has been certified as the Health and Productivity Management Outstanding Organization in the large enterprise category (White 500) by Japan's Ministry of Economy, Trade and Industry and the Nippon Kenko Kaigi. more info >> |
|
| Monday, March 7, 2022 |
|
|
LENVIMA in Combination with KEYTRUDA Approved In Taiwan for the Treatment of Patients with Advanced Endometrial Carcinoma |
| Eisai Co., Ltd. announced today that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inhibitor discovered by Eisai, in combination with Merck & Co., Inc., Kenilworth, N.J., U.S.A. more info >> |
|
| Friday, March 4, 2022 |
|
|
Eisai Initiates Submission of Application Data Under the Prior Assessment Consultation System in Japan with the Aim of Obtaining Early Approval for Investigational Anti-Amyloid Beta Protofibril Antibody Lecanemab |
| Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has initiated a submission to the Pharmaceuticals and Medical Devices Agency (PMDA) of application data under the prior assessment consultation system in Japan for the investigational anti-amyloid beta (Abeta) protofibril antibody lecanemab (BAN2401). more info >> |
|
| Friday, February 25, 2022 |
|
|
Eisai: LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Approved in Japan for Radically Unresectable or Metastatic Renal Cell Carcinoma |
| Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the combination of LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, plus KEYTRUDA. more info >> |
|
| Tuesday, February 1, 2022 |
|
|
Eisai Receives the Tokyo Governor Prize for Corporate Governance of the Year 2021 |
| Eisai Co., Ltd. announced today that it was selected as the winner of the Tokyo Governor Prize for Corporate Governance of the Year 2021, which is an award program organized by the Japan Association of Corporate Directors (JACD). more info >> |
|
| Monday, January 31, 2022 |
|
|
Eisai: Lenvima (Lenvatinib) in Combination with Keytruda (Pembrolizumab) Approved in Taiwan for the First-Line Treatment of Patients with Advanced Renal Cell Carcinoma |
| This marks the first approval for LENVIMA which will be used in combination with KEYTRUDA for advanced RCC in Asia. more info >> |
|
| Friday, January 28, 2022 |
|
|
Eisai Announces Results and Continued Support of Initiatives for Elimination of Neglected Tropical Diseases |
| Eisai Co., Ltd. announced today that its CEO Haruo Naito participated in the online event entitled "100% COMMITTED to End NTDs" celebrating the 10th anniversary of the London Declaration, an international public-private partnership to eliminate neglected tropical diseases (NTDs), on January 27, 2022. more info >> |
|
|
Eisai: Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM |
| Biogen Inc. and Eisai Co., Ltd. (Tokyo, Japan) today announced additional details about the Phase 4 post-marketing confirmatory study, ENVISION, of ADUHELM (aducanumab-avwa) 100 mg/mL injection for intravenous use in early Alzheimer's disease, including details of the study's goal for diverse enrollment and primary endpoint. more info >> |
|
| Thursday, January 20, 2022 |
|
|
Eisai: Results From Pivotal Phase 3 Study 309/KEYNOTE-775 Trial of LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Advanced Endometrial Carcinoma |
| Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced the publication of results from the Phase 3 Study 309/KEYNOTE-775 trial in the January 19, 2022 edition of the New England Journal of Medicine. more info >> |
|
| Wednesday, January 19, 2022 |
|
|
Eisai Listed as a Global 100 Most Sustainable Corporation for the Sixth Time |
| Eisai Co., Ltd. announced today that it has been listed in the 2022 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Melbourne's Deputy Lord Mayor shares city's path forward at PropertyGuru Asia Property Awards (Australia) launch
Apr 29, 2025 23:58 HKT/SGT
|
|
|
Global Sports Brand U.S. Polo Assn. Delivers Record $2.5 Billion in Retail Sales for 2024, Targets $3 Billion and 1,500 U.S. Polo Assn. Stores
Apr 29, 2025 22:48 HKT/SGT
|
|
|
The Apipatana Foundation Donates S$50,000 to Support Lower-Income Students in Singapore
Apr 29, 2025 22:47 HKT/SGT
|
|
|
HydroFleet Propels Hydrogen Revolution Forward With HTWO Logistics Collaboration in Savannah, GA
Apr 29, 2025 22:47 HKT/SGT
|
|
|
DataBurning and Vumonic Announce Strategic Partnership for India E-Receipt Data
Apr 29, 2025 22:46 HKT/SGT
|
|
|
Katalon Officially Launches TrueTest(TM) - The First AI-Native Testing System That Thinks Like a Tester and Learns from Users
Apr 29, 2025 22:00 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of Large Car Ferry KEYAKI in Shimonoseki
Apr 29, 2025 17:24 JST
|
|
|
Open Dialogue 'Future of the World. New Platform for Global Growth' Launches at Russia National Centre 
Apr 29, 2025 15:00 HKT/SGT
|
|
|
HKTDC's April lifestyle fairs open today
Apr 29, 2025 12:42 HKT/SGT
|
|
|
Azurite Medical and Wellness Launches Revolutionary Luxury Surgical Retreat Concept in Global Medical Tourism Market
Apr 29, 2025 02:09 HKT/SGT
|
|
|
Hong Kong International Licensing Show and Asian Licensing Conference Open Today
Apr 28, 2025 22:46 HKT/SGT
|
|
|
Hung Fook Tong Partners with Nutribite to Launch AI-Powered Personalised Healthy Meal Service
Apr 28, 2025 15:51 HKT/SGT
|
|
|
Q2 Metals Extends Mineralized Zone Strike Length to 1.5 Kilometres and Concludes the 2025 Winter Program at the Cisco Lithium Project in Quebec, Canada
Apr 28, 2025 15:05 HKT/SGT
|
|
|
NEC DGDF Headquarters relocates to Zurich to accelerate growth and enhance management globally
Apr 28, 2025 16:03 JST
|
|
|
Wintermar Offshore (WINS:JK) Reports 1Q2025 Results
Apr 28, 2025 11:25 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
